文献速递老年精神心境障碍

撤稿声明:L-DOPA单药治疗对高危老年抑郁症患者精神运动速度及[11C]雷氯必利结合的影响

RETRACTED: Effects of L-DOPA Monotherapy on Psychomotor Speed and [11C]Raclopride Binding in High-Risk Older Adults With Depression.
PubMed 文献 · Biol Psychiatry · 2019-04-15

该文因发现方案偏离与数据错误被《Biological Psychiatry》撤稿。问题包括:15例受试者入组时服用无效抗抑郁药(其中10例成功停药后纳入分析),8例未完成28天洗脱期(实际洗脱1-21天,均值10.1天),3例不符合抑郁量表纳入标准(CES-D各超1分),以及CONSORT图中失访与筛选失败人数错误(应为9例失访、2例筛选失败)。

要点

  • 撤稿原因:方案偏离与数据错误,涉及药物洗脱、纳入标准及受试者流程报告。
  • 15/47例受试者入组时服用无效抗抑郁药,其中10例停药后纳入分析。
  • 8例未完成28天洗脱期,实际洗脱1-21天(均值10.1天)。

核心结论

  • 因方案偏离与数据错误范围较大,编辑与作者共同决定撤稿,作者正在修订论文以供再次考虑。

研究设计与样本

  • 原文为研究L-DOPA单药治疗对高危老年抑郁症患者精神运动速度及[11C]雷氯必利结合影响的研究,样本量涉及47例知情同意受试者、36例贡献数据。

主要发现

  • 15/47例受试者入组时服用无效抗抑郁药,其中10例成功停药后纳入36例分析集。
  • 8例未完成28天洗脱期,实际药物免费期1-21天,均值10.1天。
  • 3例不符合纳入标准(CES-D评分各超范围1分)被纳入。
  • CONSORT图误将11例报告为失访,实际为9例失访和2例筛选失败。

关键数值与推荐

  • 排除标准要求过去28天内未使用影响多巴胺的精神药物或其它药物。
  • 纳入标准要求Center for Epidemiologic Studies—Depression Rating scale评分≤10。

局限性

  • 撤稿声明指出方案偏离与数据错误涉及药物洗脱、纳入标准及受试者流程报告,影响研究结果可靠性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of Biological Psychiatry Editor John H. Krystal, M.D., with agreement from all authors except Chen Chen and Emily Valente. These two co-authors moved and, with no forwarding information that was available or could be found, they were therefore unable to be contacted. The authors have uncovered irregularities and deviations from the approved protocol related to the work reported in this article. Treatment with antidepressant medications within the past 28 days was an exclusion criterion: “Subjects were excluded for… current treatment or treatment within the past 4 weeks with psychotropic or other medications known to affect dopamine.” Individuals taking an ineffective antidepressant medication who otherwise met study criteria were to undergo a study-supervised medication taper to discontinue their medication for the required period prior to study participation. The published article does not describe that a subgroup of participants (15 out of the 47 consented subjects) enrolled in the study while taking an ineffective antidepressant medication. Of this subgroup, 10 individuals were successfully tapered off their medication and were among the 36 subjects contributing data to the analyses described. In addition, the authors have found that 8 participants did not complete the required 28-day washout prior to beginning the study. For these 8 participants, the medication-free period ranged from 1 to 21 days, with a mean of 10.1 days. Separately, an inclusion criterion was that eligible subjects “had Center for Epidemiologic Studies—Depression Rating scale score ≤ 10.” However, the authors have found that 3 ineligible participants were included, each of whom had depressive symptom scores 1 point out of range for eligibility. Lastly, the CONSORT diagram in Figure S1 states that 11 participants were lost to follow-up. However, this is incorrect. Instead, 9 participants were lost to follow up and 2 participants were screen failures. The authors voluntarily informed the Journal of these honest errors upon discovery. Because of the extent of these issues, the editors and authors concluded that the only course of action was to retract this paper. However, the authors are revising the paper, which the Journal will consider further for publication.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Rutherford BR, Slifstein M, Chen C, et al. RETRACTED: Effects of L-DOPA Monotherapy on Psychomotor Speed and [11C]Raclopride Binding in High-Risk Older Adults With Depression. Biol Psychiatry. 2019. PMID: 31178096. doi:10.1016/j.biopsych.2019.04.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。